Fennec Pharmaceuticals (NASDAQ: FENC) CSO gets 156 shares from award

Rhea-AI Filing Summary

Fennec Pharmaceuticals Inc. reported that Chief Strategy Officer Christiana Marie Cioffi acquired 156 common shares on July 31, 2026 through the release of restrictions on shares awarded March 28, 2025 at a stated price of $0.0000 per share. After this compensation-related release, she directly holds 24,488 common shares.

Insider Trade Summary

Net Buyer: 156 shares

Net Buy 1 txn

Insider Cioffi Christiana Marie

Role Chief Strategy Officer

Type	Security	Shares	Price	Value
Grant/Award	Common shares F1	156	$0.00	$0.00

Holdings After Transaction: Common shares — 24,488 shares (Direct)

Footnotes (1)

1. F1. Represents shares released from restriction from shares awarded 3/28/2025.

Key Figures

Shares acquired: 156 common shares Price per share: $0.0000 per share Total holdings after transaction: 24,488 common shares +1 more

4 metrics

Shares acquired 156 common shares Grant, award, or other acquisition on July 31, 2026

Price per share $0.0000 per share Reported price for the July 31, 2026 acquisition

Total holdings after transaction 24,488 common shares Direct ownership by Christiana Marie Cioffi following the acquisition

Transaction date July 31, 2026 Date the 156 common shares were released from restriction and reported as acquired

Key Terms

Grant, award, or other acquisition, Common shares, released from restriction

3 terms

Grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition"

Common shares financial

"Security title reported as Common shares for the insider holding"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

released from restriction financial

"Represents shares released from restriction from shares awarded 3/28/2025"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/03/2026 - 04:05 PM Accepted by SEC EDGAR 08/03/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What insider transaction did FENC report for Christiana Cioffi?

Christiana Cioffi, Chief Strategy Officer of FENC, acquired 156 common shares on July 31, 2026. The shares came from a prior award dated March 28, 2025, becoming unrestricted and increasing her direct ownership to 24,488 common shares.

How many FENC shares does the CSO hold after this transaction?

After the reported transaction, Christiana Cioffi directly holds 24,488 Fennec common shares. This reflects the addition of 156 shares that were released from restrictions on a share award originally granted on March 28, 2025.

At what price were the 156 FENC shares acquired by the CSO?

The 156 FENC common shares were reported as acquired at a price of $0.0000 per share. This indicates a compensation-related share release rather than an open-market purchase, tied to an earlier equity award with restrictions that have now lapsed.

What is the nature of the 156 FENC shares acquired by the CSO?

The 156 shares are released from restriction from common shares awarded on March 28, 2025. This means previously awarded shares became unrestricted, and were reported as an acquisition rather than a new purchase of FENC stock.

Was the FENC insider transaction by Christiana Cioffi under a Rule 10b5-1 plan?

No. The transaction was not indicated as made under a Rule 10b5-1 trading plan. It reflects the release of restrictions on a prior share award, rather than trading executed pursuant to a pre-arranged trading plan.

Is Christiana Cioffi’s ownership in FENC direct or indirect after this award release?

Following the acquisition, Christiana Cioffi’s 24,488 FENC common shares are reported as held with direct ownership. No indirect ownership entities, such as trusts or LLCs, are referenced for this specific transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cioffi Christiana Marie

(Last) (First) (Middle)

C/O FENNEC PHARMACEUTICALS, INC.

PO BOX 13628, 68 TW ALEXANDER DRIVE

(Street)

RESEARCH TRIANGLE PARK NORTH CAROLINA 27709

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FENNEC PHARMACEUTICALS INC. [ FENC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Strategy Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares(1)	07/31/2026		A		156	A	$0	24,488	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares released from restriction from shares awarded 3/28/2025.

	/s/ Chritiana Cioffi	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)